Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular …
Background There have been great advances in hepatocellular carcinoma management
over the last years. However, there are still no prognostic biomarkers that can identify …
over the last years. However, there are still no prognostic biomarkers that can identify …
Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular …
T Mocan, M Ilies, I Nenu, R Craciun… - International …, 2021 - europepmc.org
Background There have been great advances in hepatocellular carcinoma management
over the last years. However, there are still no prognostic biomarkers that can identify …
over the last years. However, there are still no prognostic biomarkers that can identify …
Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular …
T Mocan, M Ilies, I Nenu, R Craciun… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Background There have been great advances in hepatocellular carcinoma management
over the last years. However, there are still no prognostic biomarkers that can identify …
over the last years. However, there are still no prognostic biomarkers that can identify …
